miR-99 is highly expressed in hematopoietic stem cells (HSCs) and acute myeloid leukemia stem cells (LSCs) and promotes their self-renewal and leukemia-initiating activity through targeting Hoxa1 (60). This evidence concerns the gene HOXA1 and acute myeloid leukemia.